0
Summaries for Patients |

Human Immunodeficiency Virus (HIV) and Invasive Pneumococcal Infections FREE

[+] Article and Author Information

The summary below is from the full report titled “Epidemiologic Relation between HIV and Invasive Pneumococcal Disease in San Francisco County, California.” It is in the 1 February 1999 issue of Annals of Internal Medicine (volume 132, pages 182-190). The authors are J.P. Nuorti, J.C. Butler, L. Gelling, J.L. Kool, A.L. Reingold, and D.J. Vugia.


Ann Intern Med. 2000;132(3):182. doi:10.7326/0003-4819-132-3-200002010-00029
Text Size: A A A

What is the problem and what is known about it so far?

The pneumococcus is one of many bacteria that attack persons infected with HIV, the virus that causes AIDS. Persons without HIV get pneumococcal infections; however, in areas where many persons are living with HIV, a sizable proportion of invasive infection with this bacterium now occurs in such persons. “Invasive” means that the infection is in a normally bacteria-free area, such as spinal fluid or blood; invasive infections are more serious. Many HIV-related illnesses are decreasing as better treatments for HIV develop, but little is known about what is happening with invasive pneumococcal infection in these patients.

Why did the researchers do this particular study?

To obtain detailed information about invasive pneumococcal infection in persons with HIV.

Who was studied?

Residents of San Francisco County, an area where many HIV-infected persons live.

How was the study done?

Every 2 weeks, between October 1994 and June 1997, the researchers contacted the 13 county bacteriology laboratories to identify all cases of invasive pneumococcal infection. They then reviewed the medical records for each case. They used census information to determine how many people lived in the county and information from the county AIDS office to estimate the number who had AIDS.

What did the researchers find?

The researchers found 602 cases of invasive pneumococcal infection. The rates of this infection per 100,000 person-years were greatest for children under 2 (118 cases) and persons over 65 (48 cases). However, the largest total number of cases (399) occurred in adults aged 18 to 64; over half of these were in persons with HIV. The rate of invasive pneumococcal infection was 46 times greater in persons with AIDS than in those without HIV. Blacks and persons in areas with the lowest household incomes were at greatest risk. The rate of invasive pneumococcal infection in persons with AIDS decreased over the study period from 10.6 cases to 4.2 cases per 100,000 person-years. Over 80% of the types of pneumococci found can be protected against by the available pneumococcal vaccine.

What were the limitations of the study?

The same results may not be found in other geographic areas. The researchers could not be certain that they had identified all people with HIV infection. They also were not able to investigate whether the risk for invasive pneumococcal disease was lower in people who took anti-HIV drugs or were vaccinated against pneumococcus.

What are the implications of the study?

A large proportion of all invasive pneumococcal infection currently occurs in persons infected with HIV; black persons and persons with low incomes appear to be at highest risk. Available vaccine can protect against most types of pneumococci found in these invasive infections, but little is known about the effectiveness of the vaccine in HIV-infected persons. Rates of infection decreased between 1994 and 1997, possibly due to better treatment of underlying HIV infection or greater use of pneumococcal vaccine.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Topic Collections
PubMed Articles

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)